Cargando…

High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement

Overexpression of cytokine receptor-like factor 2 (CRLF2) due to chromosomal rearrangement has been observed in acute lymphoblastic leukemia (ALL) and reported to contribute to oncogenesis and unfavorable outcome in ALL. We studied B-ALL and T-ALL patients without CRLF2 rearrangement and observed th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Zheng, Gu, Yan, Zhao, Gang, Li, Jianyong, Chen, Baoan, Han, Qi, Guo, Xing, Liu, Juan, Li, Hui, Yu, Michael D., Olson, Justin, Steffens, Sadie, Payne, Kimberly J., Song, Chunhua, Dovat, Sinisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226542/ https://www.ncbi.nlm.nih.gov/pubmed/27391346 http://dx.doi.org/10.18632/oncotarget.10437

Ejemplares similares

P344: ONCOGENESIS OF CRLF2 OVEREXPRESSION AND EFFECT OF A NOVEL JAK2 INHIBITOR IN CRLF2 OVEREXPRESSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Gu, Yan, et al.
Publicado: (2023)

TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia
por: Alkashgari, Hossam R., et al.
Publicado: (2022)

Characterisation of the genomic landscape of CRLF2‐rearranged acute lymphoblastic leukemia
por: Russell, Lisa J., et al.
Publicado: (2017)

Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia
por: Mittelman, Steven D., et al.
Publicado: (2021)

Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children—a novel health disparity
por: Raca, Gordana, et al.
Publicado: (2021)

BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia
por: Tsuzuki, Shinobu, et al.
Publicado: (2022)

CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways
por: Moreno Lorenzana, Dafné, et al.
Publicado: (2021)

IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia
por: Maciel, Ana Luiza Tardem, et al.
Publicado: (2021)

CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition
por: Meyer, Lauren K., et al.
Publicado: (2019)

Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia
por: Noronha, Elda Pereira, et al.
Publicado: (2023)

Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children
por: Wang, Mingmin, et al.
Publicado: (2019)

Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia
por: Vesely, C, et al.
Publicado: (2017)

Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2016)

The enigmatic role(s) of P2RY8-CRLF2
por: Panzer-Grümayer, Renate, et al.
Publicado: (2017)

CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia
por: Palmi, Chiara, et al.
Publicado: (2016)

SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia
por: Sarno, Jolanda, et al.
Publicado: (2018)

RAG1 high expression associated with IKZF1 dysfunction in adult B-cell acute lymphoblastic leukemia
por: Han, Qi, et al.
Publicado: (2019)

CRLF1 and CLCF1 in Development, Health and Disease
por: Crisponi, Laura, et al.
Publicado: (2022)

CRLF1 Is a Key Regulator in the Ligamentum Flavum Hypertrophy
por: Zheng, Zhenyu, et al.
Publicado: (2020)

Potential efficacy and prognosis of silencing the CRLF2-mediated AKT/mTOR pathway in pediatric acute B-cell lymphoblastic leukemia
por: Jiang, Min, et al.
Publicado: (2019)

Single cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia
por: Potter, N, et al.
Publicado: (2018)

Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes
por: Lin, Danna, et al.
Publicado: (2023)

Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia
por: Ge, Zheng, et al.
Publicado: (2016)

Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction
por: Ge, Zheng, et al.
Publicado: (2016)

Corrigendum: Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia
por: Ge, Zheng, et al.
Publicado: (2017)

Gain of chromosome 21 increases the propensity for P2RY8: :CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression
por: Page, Elyse C., et al.
Publicado: (2023)

Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome–like acute B-cell lymphoblastic leukemia
por: Zhang, Qi, et al.
Publicado: (2018)

Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL
por: Tian, Ze, et al.
Publicado: (2023)

P2RY8-CRLF2 Fusion–Positive Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Response to Novel Therapy
por: Aypar, Umut, et al.
Publicado: (2020)

Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2015)

Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia
por: Guo, Xing, et al.
Publicado: (2015)

Increased AID Results in Mutations at the CRLF2 Locus Implicated in Latin American ALL Health Disparities
por: Pannunzio, Nicholas, et al.
Publicado: (2023)

A novel approach for direct detection of the IGH::CRLF2 gene fusion by fluorescent in situ hybridization
por: González-Arreola, Rosa María, et al.
Publicado: (2023)

Cytokine Receptor-Like Factor 3 (CRLF3) Contributes to Early Zebrafish Hematopoiesis
por: Taznin, Tarannum, et al.
Publicado: (2022)

Protection of insect neurons by erythropoietin/CRLF3-mediated regulation of pro-apoptotic acetylcholinesterase
por: Knorr, Debbra Y., et al.
Publicado: (2022)

The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor
por: Knorr, Debbra Y., et al.
Publicado: (2023)

P1421: BIMODAL TARGETING OF CYTOKINE RECEPTOR-LIKE FACTOR 2 (CRLF2) WITH JAK INHIBITION AND CHIMERIC ANTIGEN RECEPTOR T CELL IMMUNOTHERAPY IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA
por: Bagashev, A., et al.
Publicado: (2022)

Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2018)

The Insect Ortholog of the Human Orphan Cytokine Receptor CRLF3 Is a Neuroprotective Erythropoietin Receptor
por: Hahn, Nina, et al.
Publicado: (2017)

Locust Hemolymph Conveys Erythropoietin-Like Cytoprotection via Activation of the Cytokine Receptor CRLF3
por: Knorr, Debbra Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qpkocdtebb6lq0bgg2od6u8fic